Ardelyx, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ARDX Nasdaq 2836 www.ardelyx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Ardelyx, Inc.

Ardelyx (ARDX) Stock Looks Cheap Relative To Its Sales Base - Nov 4th, 2026 3:16 pm
Ardelyx (ARDX) Results And IBSRELA Progress Put Its Valuation Story Back In Focus - Nov 4th, 2026 2:11 pm
Ardelyx: 3 Key Takeaways for Long-Term Investors - Nov 4th, 2026 8:27 am
Ardelyx (ARDX) Q3 2026 Earnings Call Transcript - Nov 4th, 2026 8:00 am
Ardelyx, Inc. Q3 2026 Earnings Call Summary - Nov 4th, 2026 6:30 am
Ardelyx Inc (ARDX) (Q3 2026) Earnings Call Highlights: Revenue Climbs 19% as IBSRELA Shines and ... - Nov 3rd, 2026 10:12 pm
What Ardelyx (ARDX) Said on Its Q3 Earnings Call - Nov 3rd, 2026 5:14 pm
Ardelyx (ARDX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Nov 3rd, 2026 2:30 pm
Ardelyx: Q3 Earnings Snapshot - Nov 3rd, 2026 2:19 pm
Ardelyx (ARDX) Reports Break-Even Earnings for Q3 - Nov 3rd, 2026 2:15 pm
Ardelyx Reports Third Quarter 2026 Financial Results and Provides Business Update - Nov 3rd, 2026 2:01 pm
Ardelyx Completes Enrollment in Phase 3 ACCEL Clinical Trial of IBSRELA® (tenapanor) in Adults with Chronic Idiopathic Constipation - Nov 3rd, 2026 6:00 am
Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate Binders - Oct 23rd, 2026 2:01 pm
Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026 - Oct 20th, 2026 5:30 am
Ardelyx Presents Real-World Data at ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA® Initiation in Adults with IBS-C - Oct 12th, 2026 6:01 am
New Strong Sell Stocks for October 9th - Oct 9th, 2026 3:12 am
New Strong Sell Stocks for October 7th - Oct 7th, 2026 12:23 am
Ardelyx to Present New Data on Hyperphosphatemia Management at ASN Kidney Week 2026 - Oct 5th, 2026 6:01 am
Ardelyx Earns Multiple Honors at the 2026 PM360 Trailblazer Awards - Sep 30th, 2026 6:01 am
Ardelyx Targets $500M Revenue This Year, Profitability by 2027 - Sep 21st, 2026 2:02 am